期刊文献+

替米沙坦治疗原发性高血压逆转左心室肥厚的临床观察 被引量:2

Clinic Evaluation of Telmisartan in Treatment of Essential Hypertension and Reverse Left Ventricular Hypertrophy.
暂未订购
导出
摘要 目的 观察替米沙坦治疗轻、中度原发性高血压疗效、安全性和左心室肥厚的逆转作用。方法  12 0例高血压患者服用替米沙坦 40 -80mg/d ,连服 2 8周。每周测血压一次 ,试验前、试验末各查 2 4h动态血压、心脏彩色多普勒超声。结果 替米沙坦能有效降低血压 ,降压总有效率达 78% ,疗效显著 ,且可逆转左心室肥厚、改善左心室舒张功能(p <0 .0 1)。结论 替米沙坦疗效确切 ,对左心室肥厚有逆转作用 。 Objective To evaluate the efficacy and safety of telmisartan in patients with mild or moderate essential hypertension.Methods 120 patients with mild or moderate essential hypertension were studied.The patients took telmisartan 40-80 mg daily for 28 weeks.Before and after 28 week's therapy ,24-hour non-invasive ambulatory blood pressure monitorig and color Doppler Echocardiographic examination were performed.Results Telmisartan was effective on reducing blood pressure,reversing left ventricular hypertrophy and improving left ventricular diastolic function.Conclusions Telmisartan is effcetive and well tolerable in patients with essential hypertension,it may significantly reverse left ventricular hypertrophy.
作者 方志高 刘峰
出处 《心脑血管病防治》 2003年第2期9-10,13,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 替米沙坦 治疗 原发性高血压 左心室肥厚 疗效 安全性 Telmisartan Essential hypertension Left ventricular hypertrophy
  • 相关文献

参考文献7

  • 1[1]Goodriend T L,Elliott ME,Catt K J.Angiotensin receptors and their antagonists.NEngl J Med,1996,334:1649~1654.
  • 2周和,伍爱婵.高血压病的诊断进展[J].新医学,2000,31(1):45-47. 被引量:44
  • 3[3]Myers MG.Trough-to-peak ratio and 24-hour blood pressure control:Methodolgic issue,A M J Hypertens,1995,8:214~219.
  • 4[5]WHO-ISH Hypertension Guidelines Committee,1999 World Health Organization-International Society of Hypertension guide-lines for the management of hypertension.J Hypertension,1999,17(2):151~185.
  • 5[6]Hauel N H,Ries UJ,van Meel JCA,et al.Chemistry of telmisartan,a highly lipophilic angiotensinⅡ antagonist with a long duration of action,Presented at:Ist International Symposium on AnigotensinⅡ Antagonism,London,UK 28 september-1 October 1997,AbstractP16.
  • 6[7]Wienen W,Hauel N,van Meel J C A,et al.pharmacological characterization of the novel nonpeptide angiotensin Ⅱ receptor antagonist,BIBR 277.Br J Pharmacol,1993,110:245~252.
  • 7[9]Smith DHG,Neutel JM,Morgenstern P.Once-daily telmisartan compared with enalapril in the treatment of hypertension.Adv Ther,1998,15:229~240.

共引文献43

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部